Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-24 @ 3:37 PM
NCT ID:
NCT00032292
Eligibility Criteria:
* Patients who develop Grade II, III, or IV acute GVHD following allogeneic hematopoietic cell transplantation
* Patients receiving GVHD prophylaxis including cyclosporine or tacrolimus
* Clinical findings: skin thickening, joint contraction, oral ulceration, diarrhea.
* Patients with an onset date of acute GVHD that is less than or equal to 100 days posttransplant.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00032292
Study Brief:
Protocol Section:
NCT00032292